A study on the expression of myostatin in preeclampsia revealed elevated levels of myostatin in the plasma of women who later developed this disorder, which can suggest the potential usage of plasma myostatin as biomarker in preeclampsia [186]. The gene discussed is MSTN; the disease is preeclampsia.